Melanotan II

Melanotan II (MT2) is a synthetic peptide that acts as an agonist of melanocortin receptors (MC1R, MC3R, MC4R and MC5R). Its primary studied function is stimulating the production of melanin, the pigment that gives skin its colour, which is associated with a tanning effect.

Research has also explored MT2 in relation to appetite regulation, potentially through its interaction with the MC4R receptor, and in relation to libido and sexual wellness.

Melanotan II is not approved for medical use by the FDA and is listed by the World Anti-Doping Agency. Its use is associated with possible risks and side effects, including nausea, flushing, increased blood pressure, and moles or freckles appearing or becoming darker. It is important to consult a healthcare professional before use, and any use should be physician-supervised.

• May help support libido
• Associated with tanning with less UV exposure
• May help support body composition as part of a wider routine
• Reduced likelihood of tan lines compared with UV tanning
• No streaking associated with topical sunless tanning products

Research has explored a potential relationship between MT2 and appetite regulation. Findings are ongoing, individual responses vary, and no specific outcome can be guaranteed. Your physician can discuss what is currently known during your consultation.

MT2 activates melanocortin receptors in the body, which are involved in producing melanin, the pigment responsible for skin color. This results in a tanning effect even without sun exposure.

Melanotan II is typically administered through subcutaneous injection. Dosage and frequency are determined by your prescribing physician based on your individual circumstances.

Possible side effects include nausea, flushing, changes in libido and darkening of moles or freckles. Melanotan II is not approved for medical use by the FDA. It is important to monitor for any adverse effects and discuss them with your healthcare provider promptly.